CLBT
Cellebrite DI Ltd.Company with tickers: CLBT
CIK
1854587
CUSIP
M2197Q107
Shares Outstanding
249,439,817
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $475,675,000 | USD | 2025-12-31 | 20-F | 2026-03-03 |
| Cost of Revenue | $75,172,000 | USD | 2025-12-31 | 20-F | 2026-03-03 |
| Gross Profit | $400,503,000 | USD | 2025-12-31 | 20-F | 2026-03-03 |
| Operating Expenses | $334,023,000 | USD | 2025-12-31 | 20-F | 2026-03-03 |
| Research & Development | $113,877,000 | USD | 2025-12-31 | 20-F | 2026-03-03 |
| Operating Income | $66,480,000 | USD | 2025-12-31 | 20-F | 2026-03-03 |
| Net Income | $78,326,000 | USD | 2025-12-31 | 20-F | 2026-03-03 |
| EPS (Basic) | $0.32 | USD/shares | 2025-12-31 | 20-F | 2026-03-03 |
| EPS (Diluted) | $0.31 | USD/shares | 2025-12-31 | 20-F | 2026-03-03 |